Cure Brain Cancer Foundation invests in GBM AGILE, connecting Australians to an innovative clinical trial program...
Cure Brain Cancer Foundation invests in GBM AGILE, connecting Australians to an innovative clinical trial program...
Cure Brain Cancer Foundation is thrilled to announce the launch of our first ever Mid-Career Fellowship...
GBM AGILE, the groundbreaking clinical trial, is now open for enrollment in Australia. Patients at Royal...
Insights from Dr. Marcelle Moore, Clinical Psychologist and Author of Even Lions Get Scared. When a...
We are thrilled to announce Dr. Susannah Hallal is the winner of our 2025 Guardian Trust...
Group leader at the Sid Faithfull Brain Cancer Laboratory at QIMR Berghofer Medical Research Institute, Queensland,...
Cure Brain Cancer Foundation CEO Lance Kawaguchi rang the bell to open trading on the Nasdaq...
The Foundation is excited to share a final update from Prof. Bryan Day, Group Leader of...
Dr. Hsiao Voon was the recipient of our inaugural Mid-Career Fellowship in 2022. Based at Monash...
Cure Brain Cancer Foundation (CBCF) is pleased to share a final report from the team at...